Uterine sarcomas are malignant tumors that originate in the smooth muscle tissue of the uterus, the interstitium of the uterus, and other parts of the uterus. Common uterine sarcomas include uterine smooth muscle sarcoma, endometrial mesenchymal sarcoma, and uterine carcinosarcoma, all of which are malignant tumors. The main symptom of uterine sarcoma is a rapidly enlarging mass in the lower abdomen. The enlarged uterus may cause pressure on the adjacent organs, resulting in difficulty in urination and defecation. In addition, patients with uterine sarcoma may also have irregular bleeding, and advanced uterine sarcoma may present with malignant fluid manifestations such as lethargy and fatigue. Uterine sarcoma is mainly treated by surgery. For patients with hormone-sensitive tumors, postoperative supplemental hormone therapy is needed, while uterine cancer sarcoma with high malignancy requires adjuvant chemotherapy. Female patients are advised to go to the hospital for regular medical checkups, strive for early detection and diagnosis, and follow the specialist’s advice to standardize the treatment in order to improve the prognosis of the disease.